Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-5b777bbd6c-2c8nx Total loading time: 0 Render date: 2025-06-19T09:52:17.907Z Has data issue: false hasContentIssue false

10 - Staging Systems for Hepatocellular Carcinoma

from PART III - ORGAN-SPECIFIC CANCERS

Published online by Cambridge University Press:  18 May 2010

By
Debashish Bose  and
Timothy M. Pawlik
Edited by
Jean-François H. Geschwind  and
Michael C. Soulen
Debashish Bose
Affiliation:
Assistant Professor, Department of Surgery Johns Hopkins University School of Medicine Baltimore, MD
Timothy M. Pawlik
Affiliation:
Assistant Professor, Department of Surgery Johns Hopkins University School of Medicine Baltimore, MD
Jean-François H. Geschwind
Affiliation:
The Johns Hopkins University School of Medicine
Michael C. Soulen
Affiliation:
University of Pennsylvania School of Medicine
Get access

Summary

Accurate staging of hepatocellular carcinoma (HCC) is important because it provides prognostic data as well as aids in selecting patients for appropriate clinical treatment regimens (1). Many previous studies, however, have noted differing predictors of survival following treatment of HCC (2–5). A number of staging systems have therefore been proposed, including some that rely mostly on clinical parameters [Okuda, Cancer of the Liver Italian Program (CLIP)] and others that utilize pathologic data [American Joint Committee on Cancer/International Union Against Cancer (AJCC/UICC)]. This chapter provides an overview of the major HCC staging systems and highlights the relative merits of each staging scheme.

CHILD-TURCOTTE-PUGH NOMINAL SCORE

Although not a true prognostic staging scheme for HCC, the Child-Turcotte-Pugh (CTP) score is the most basic scoring system for the assessment of liver disease. The Child-Pugh score assigns points for degree of liver dysfunction based on three biochemical markers (serum albumin, bilirubin and prothrombin time) and two clinical markers (ascites and encephalopathy) (Table 10.1). The CTP score is not an assessment of HCC stage, but it is a well-established predictor of surgical risk and prognosis in patients with liver disease. The CTP score is included here because it is used as a component of several formal HCC staging systems.

OKUDA STAGING SYSTEM

In 1985, Okuda proposed a HCC staging system based on both serum liver function tests and tumor extension (6).

Type
Chapter
Information
Interventional Oncology
Principles and Practice
 , pp. 107 - 114
Publisher: Cambridge University Press
Print publication year: 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Book purchase

Temporarily unavailable

References

Pawlik, T M, Tseng, J F, Vauthey, J N. Controversies in staging of hepatocellular carcinoma. Cancer Reviews: Asia-Pacific 2003; 1: 179–189.CrossRefGoogle Scholar
Vauthey, J N, Klimstra, D, Franceschi, D, et al. Factors affecting long-term outcome after hepatic resection for hepatocellular carcinoma. Am J Surg 1995; 169: 28–34; discussion 34–35.CrossRefGoogle ScholarPubMed
Ikai, I, Yamamoto, Y, Yamamoto, N, et al. Results of hepatic resection for hepatocellular carcinoma invading major portal and/or hepatic veins. Surg Oncol Clin North Am 2003; 12: 65–75, ix.CrossRefGoogle ScholarPubMed
Fong, Y, Sun, R L, Jarnagin, W, et al. An analysis of 412 cases of hepatocellular carcinoma at a Western center. Ann Surg 1999; 229: 790–799; discussion 799–800.CrossRefGoogle Scholar
Kosuge, T, Makuuchi, M, Takayama, T, et al. Long-term results after resection of hepatocellular carcinoma: Experience of 480 cases. Hepatogastroenterology 1993; 40: 328–332.Google ScholarPubMed
Okuda, K, Ohtsuki, T, Obata, H, et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment: Study of 850 patients. Cancer 1985; 56: 918–928.3.0.CO;2-E>CrossRefGoogle ScholarPubMed
Kudo, M, Chung, H, Osaki, Y. Prognostic staging system for hepatocellular carcinoma (CLIP score): Its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score). J Gastroenterol 2003; 38: 207–215.CrossRefGoogle Scholar
The Cancer of the Liver Italian Program (CLIP) investigators. A new prognostic system for hepatocellular carcinoma: A retrospective study of 435 patients. Hepatology 1998; 28: 751–755.CrossRef
The Cancer of the Liver Italian Program (CLIP) Investigators. Prospective validation of the CLIP score: A new prognostic system for patients with cirrhosis and hepatocellular carcinoma. Hepatology 2000; 31: 840–845.
Levy, I, Sherman, M. Staging of hepatocellular carcinoma: Assessment of the CLIP, Okuda, and Child-Pugh staging systems in a cohort of 257 patients in Toronto. Gut 2002; 50: 881–885.CrossRefGoogle Scholar
Ueno, S, Tanabe, G, Nuruki, K, et al. Prognostic performance of the new classification of primary liver cancer of Japan (4th ed) for patients with hepatocellular carcinoma: A validation analysis. Hepatol Res 2002; 24: 395–403.CrossRefGoogle Scholar
Llovet, J M, Bru, C, Bruix, J. Prognosis of hepatocellular carcinoma: The BCLC staging classification. Semin Liver Dis 1999; 19: 329–338.CrossRefGoogle ScholarPubMed
Ng, K K, Vauthey, J N, Pawlik, T M, et al. Is hepatic resection for large or multinodular hepatocellular carcinoma justified? Results from a multi-institutional database. Ann Surg Oncol 2005; 12: 364–373.CrossRefGoogle ScholarPubMed
Pawlik, T M, Poon, R T, Abdalla, E K, et al. Critical appraisal of the clinical and pathologic predictors of survival after resection of large hepatocellular carcinoma. Arch Surg 2005; 140: 450–457; discussion 457–458.CrossRefGoogle ScholarPubMed
Leung, T W, Tang, A M, Zee, B, et al. Construction of the Chinese University Prognostic Index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the Cancer of the Liver Italian Program staging system: A study based on 926 patients. Cancer 2002; 94: 1760–1769.CrossRefGoogle ScholarPubMed
Makuuchi, M, Belghiti, J, Belli, G, et al. IHPBA concordant classification of primary liver cancer: Working group report. J Hepatobiliary Pancreat Surg 2003; 10: 26–30.Google ScholarPubMed
Poon, R T, Fan, S T. Evaluation of the new AJCC/UICC staging system for hepatocellular carcinoma after hepatic resection in Chinese patients. Surg Oncol Clin North Am 2003; 12: 35–50, viii.CrossRefGoogle ScholarPubMed
Staudacher, C, Chiappa, A, Biella, F, et al. Validation of the modified TNM-Izumi classification for hepatocellular carcinoma. Tumori 2000; 86: 8–11.CrossRefGoogle ScholarPubMed
Izumi, R, Shimizu, K, Ii, T, et al. Prognostic factors of hepatocellular carcinoma in patients undergoing hepatic resection. Gastroenterology 1994; 106: 720–727.CrossRefGoogle ScholarPubMed
Vauthey, J N, Lauwers, G Y, Esnaola, N F, et al. Simplified staging for hepatocellular carcinoma. J Clin Oncol 2002; 20: 1527–1536.CrossRefGoogle ScholarPubMed
Liver (Including intrahepatic bile ducts). In: Green, F, Page, D, , I. F. (eds)., AJCC Cancer Staging Handbook, pp. 131–144. New York: Springer 2002.CrossRefGoogle Scholar
Ishak, K, Baptista, A, Bianchi, L, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995; 22: 696–699.CrossRefGoogle ScholarPubMed
Marrero, J A, Fontana, R J, Barrat, A, et al. Prognosis of hepatocellular carcinoma: Comparison of 7 staging systems in an American cohort. Hepatology 2005; 41: 707–716.CrossRefGoogle Scholar
Pawlik, T M, Abdalla, E K, Thomas, M, et al. Staging of hepatocellular carcinoma. Hepatology 2005; 42: 738–739; author reply 739–740.CrossRefGoogle ScholarPubMed
Cillo, U, Vitale, A, Grigoletto, F, et al. Prospective validation of the Barcelona Clinic Liver Cancer staging system. J Hepatol 2006; 44: 723–731.CrossRefGoogle ScholarPubMed
Tateishi, R, Yoshida, H, Shiina, S, et al. Proposal of a new prognostic model for hepatocellular carcinoma: An analysis of 403 patients. Gut 2005; 54: 419–425.CrossRefGoogle ScholarPubMed
Toyoda, H, Kumada, T, Kiriyama, S, et al. Comparison of the usefulness of three staging systems for hepatocellular carcinoma (CLIP, BCLC, and JIS) in Japan. Am J Gastroenterol 2005; 100: 1764–1771.CrossRefGoogle Scholar
Nanashima, A, Omagari, K, Tobinaga, S, et al. Comparative study of survival of patients with hepatocellular carcinoma predicted by different staging systems using multivariate analysis. Eur J Surg Oncol 2005; 31: 882–890.CrossRefGoogle ScholarPubMed
Ueno, S, Tanabe, G, Sako, K, et al. Discrimination value of the new Western prognostic system (CLIP score) for hepatocellular carcinoma in 662 Japanese patients. Cancer of the Liver Italian Program. Hepatology 2001; 34: 529–534.CrossRefGoogle ScholarPubMed
Testa, R, Testa, E, Giannini, E, et al. Trans-catheter arterial chemoembolisation for hepatocellular carcinoma in patients with viral cirrhosis: Role of combined staging systems, Cancer Liver Italian Program (CLIP) and Model for End-stage Liver Disease (MELD), in predicting outcome after treatment. Aliment Pharmacol Ther 2003; 17: 1563–1569.CrossRefGoogle Scholar
Biselli, M, Andreone, P, Gramenzi, A, et al. Transcatheter arterial chemoembolization therapy for patients with hepatocellular carcinoma: A case-controlled study. Clin Gastroenterol Hepatol 2005; 3: 918–925.CrossRefGoogle ScholarPubMed
Grieco, A, Pompili, M, Caminiti, G, et al. Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing non-surgical therapy: Comparison of Okuda, CLIP, and BCLC staging systems in a single Italian centre. Gut 2005; 54: 411–418.CrossRefGoogle Scholar
Georgiades, C S, Hong, K, D'Angelo, M, et al. Safety and efficacy of transarterial chemoembolization in patients with unresectable hepatocellular carcinoma and portal vein thrombosis. J Vasc Interv Radiol 2005; 16: 1653–1659.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×